Rapamycin reduces rejection in heart transplant recipients.
Radovancevic
B
B
Texas Heart Institute, Houston, Texas 77030, USA
El-Sabrout
R
R
Thomas
C
C
Radovancevic
R
R
Frazier
O H
OH
Van Buren
C
C
D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005006:Ethnicity; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000627:therapeutic use*; D013781:Texas
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus